- Home
- CATO vs ZYXI Comparison
CATO vs ZYXI Comparison
Compare CATO & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- ZYXI
- Stock Information
- Founded
- CATO 1946
- ZYXI 1996
- Country
- CATO United States
- ZYXI United States
- Employees
- CATO N/A
- ZYXI N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CATO Consumer Discretionary
- ZYXI Health Care
- Exchange
- CATO Nasdaq
- ZYXI Nasdaq
- Market Cap
- CATO 63.9M
- ZYXI 66.5M
- IPO Year
- CATO N/A
- ZYXI N/A
- Fundamental
- Price
- CATO $2.45
- ZYXI $2.18
- Analyst Decision
- CATO
- ZYXI Buy
- Analyst Count
- CATO 0
- ZYXI 3
- Target Price
- CATO N/A
- ZYXI $10.25
- AVG Volume (30 Days)
- CATO 80.4K
- ZYXI 262.3K
- Earning Date
- CATO 05-22-2025
- ZYXI 04-29-2025
- Dividend Yield
- CATO 13.96%
- ZYXI N/A
- EPS Growth
- CATO N/A
- ZYXI N/A
- EPS
- CATO N/A
- ZYXI 0.09
- Revenue
- CATO $649,806,000.00
- ZYXI $192,354,000.00
- Revenue This Year
- CATO N/A
- ZYXI N/A
- Revenue Next Year
- CATO N/A
- ZYXI $23.16
- P/E Ratio
- CATO N/A
- ZYXI $24.22
- Revenue Growth
- CATO N/A
- ZYXI 4.36
- 52 Week Low
- CATO $2.19
- ZYXI $1.93
- 52 Week High
- CATO $6.70
- ZYXI $12.19
- Technical
- Relative Strength Index (RSI)
- CATO 38.68
- ZYXI 26.14
- Support Level
- CATO $2.19
- ZYXI $2.03
- Resistance Level
- CATO $2.97
- ZYXI $2.24
- Average True Range (ATR)
- CATO 0.27
- ZYXI 0.18
- MACD
- CATO -0.07
- ZYXI 0.17
- Stochastic Oscillator
- CATO 16.35
- ZYXI 38.46
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.